US 9127274
Serpinc1 iRNA compositions and methods of use thereof
granted A61KA61K31/713A61P
Quick answer
US patent 9127274 (Serpinc1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61K, A61K31/713, A61P, A61P43/00, A61P7/04